Bethesda, Maryland 20892

  • term Effects Secondary to Cancer Therapy in Adults


RATIONALE: Gathering health information from patients who received breast cancer treatment may help doctors better understand the effects of treatment. PURPOSE: This clinical trial is gathering health information from patients who received breast cancer treatment and from those who did not to determine the physical and psychological effects of breast cancer treatment.

Study summary:

OBJECTIVES: - Determine the frequency and severity of symptom distress, pathological conditions, physical impairments, functional limitations, and disabilities during the course of medical treatment. - Strengthen the morbidity risk factor model developed in a previous retrospective study. OUTLINE: This is a multicenter study. Information about demographics; past medical history; family history; current medical illness and treatment; pain history; and social, physical, and recreational activities is obtained by patient interview and medical record review at baseline and at 1, 3, 6, 12, 18, and 24 months. Patients undergo standard upper body clinical physical exams (weight, height, range of motion, strength, upper limb lift testing, and arm girth) by a physical therapist at the same time points. Patients also complete the Upper Limb Disability Questionnaire, Quality of Life Questionnaire, and Physical Activity Questionnaire at baseline and at 6, 12, 18, and 24 months.


DISEASE CHARACTERISTICS: - Meets one of the following criteria: - Histologically confirmed stage I-IIIC breast cancer - Referred to the National Naval Medical Center Breast Care Center (NNMC-BCC) for the diagnosis and management (i.e., surgery and radiotherapy or chemotherapy) of breast cancer in 2001-2010 - Has undergone an excisional biopsy at the NNMC-BCC in 2001-2010 AND is negative for breast cancer - Hormone receptor status not specified PATIENT CHARACTERISTICS: - Female - Menopausal status not specified - Must be post-puberty - Able to complete the clinical examination tests and questionnaires/surveys PRIOR CONCURRENT THERAPY: - See Disease Characteristics



Primary Contact:

Principal Investigator
Ellen W. Levy
NIH - Warren Grant Magnuson Clinical Center

Backup Contact:


Location Contact:

Bethesda, Maryland 20892
United States

Clinical Trials Office - Warren Grant Magnusen Clinical Center
Phone: 888-NCI-1937

Site Status: Recruiting

Data Source:

Date Processed: February 03, 2023

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.